There are a ton of biotechs now, and many are vying for those headlines. Most have already come back down from those pops. Not what I want for GNBT/NGIO. Although $10 a share would have looked nice on my account balance.

I like the way they handled it over all for the most part. I probably would have waited until now to say anything. Would prefer some concrete details. It has been good re-familiarizing myself with the tech stuff we haven't heard of in a while. That is a plus.